Health Minister Robin Swann has welcomed the advice on Covid booster vaccinations from the Joint Committee on Vaccination and Immunisation (JCVI).
The interim advice from JCVI is to plan to offer booster vaccines from September 2021 to maintain protection given by first and second doses.
The Minister said: “Today’s announcement by JCVI is welcome news which allows us to plan a booster programme for early autumn. The huge success of the vaccination programme in Northern Ireland is undoubtedly saving lives and is key to delivering a roadmap out of the pandemic. The booster programme will provide additional protection for our most vulnerable and will help protect our health service ahead of the winter months.”
The final JCVI advice will be published before September and will take into account the latest epidemiological situation, additional scientific data from trials such as Cov-Boost, real-time surveillance of the effectiveness of the vaccines over time and emerging variants. The final advice could change from the interim advice as further data is analysed.
The Chief Medical Officer, Professor Sir Michael McBride said: “Booster vaccines will prolong the protection already offered by first and second doses and provide an additional advantage in the fight against Covid. Whilst final advice may change, we can now plan and prepare so that our preparations are complete and our programme is ready to adapt and deliver in the autumn.”
Notes to editors:
- For media enquiries please contact DoH Press Office by email: pressoffice@health-ni.gov.uk.
- Follow us on twitter @healthdpt.
- The Executive Information Service operates an out of hours service For Media Enquiries Only between 1800hrs and 0800hrs Monday to Friday and at weekends and public holidays. The duty press officer can be contacted on 028 9037 8110.
Latest news
- Innovative services bringing real benefit to patients – Swann 01 May 2024
- Emergency Care Waiting Time Statistics (January - March 2024) 25 April 2024
- Dentists' Working Patterns, Motivation and Morale - 2022/23 25 April 2024
- Expansion of patient groups eligible for Paxlovid treatment for COVID-19 25 April 2024